Aziz Hassan, Genyk Yuri, Saif Muhammad Wasif, Filkins Alexandra, Selby Rick, Sheikh Mohd Raashid
Hepatobiliary, pancreas, and Abdominal Transplant, Keck Hospital of University of Southern California, USA.
Northwell Health Cancer Institute, Lake Success, NY, USA.
Cancer Med J. 2021 Apr 1;4(1):16-26.
Jehovah's Witnesses undergoing liver or pancreas surgery represent a unique medical and ethical challenge. For hepatic and pancreatic malignancies, resections are currently the only curative treatment. These surgeries pose a risk for significant blood loss, for which blood transfusions are traditionally given. However, blood transfusions are considered unacceptable to many Jehovah's Witnesses patients. As the technology of surgery as well as development of new products continue to evolve, transfusion-less surgery modalities have been utilized for Jehovah's Witnesses. The use of these transfusion-less techniques is not yet standardized for hepatic and pancreatic resections. We aimed to review both oncology and transplant medical literature on pancreatic and hepatic resection to develop guidelines for the management Jehovah's Witnesses patients.
接受肝脏或胰腺手术的耶和华见证人代表着独特的医学和伦理挑战。对于肝脏和胰腺恶性肿瘤,目前手术切除是唯一的治愈性治疗方法。这些手术存在大量失血的风险,传统上会进行输血治疗。然而,许多耶和华见证人患者认为输血是不可接受的。随着手术技术和新产品的不断发展,无输血手术方式已应用于耶和华见证人患者。这些无输血技术在肝脏和胰腺切除术中的应用尚未标准化。我们旨在回顾肿瘤学和移植医学文献中关于胰腺和肝脏切除的内容,以制定管理耶和华见证人患者的指南。